Navigation Links
Maryland Stem Cell Research Commission Recommends 62 Projects for Funding
Date:5/8/2008

the proposals considered by the Commission had already been judged to have high scientific merit, through the scientific peer review process," said Linda Powers, chairperson of the Commission. "We are excited about the potential future applications of these funded projects in diseases such as Parkinson's, ALS, brain cancer and arthritis, as well as in new enabling technologies such as non-invasive imaging, and in some fundamental biology for the prevention of teratomas or tumors."

Grants awarded from the MSCRF are contingent upon the Principal Investigator having obtained all applicable approvals from an Institutional Review Board (IRB), an Institutional Animal Care and Use Committee (IACUC), and having signed an agreement with TEDCO setting forth the scope of each project and the requirements relating to diligent execution of the project, sharing of any new cells lines, publication of results, and the like. The amounts of the awards will be disclosed once final terms are negotiated and the agreements are signed with the Principal Investigators. Research activity can then begin immediately.

The goals of the MSCRF are to broaden and advance basic knowledge of human stem cell biology that will be relevant for eventual development of clinical applications, and to enable, support and accelerate such clinical applications for prevention, diagnosis and treatment of human diseases and conditions. The Commission sought the widest range of research topics that may achieve these goals.

The work funded must be conducted in Maryland. The scientists and clinicians conducting the work must be employed or retained by an eligible Maryland-based organization while doing so. Such employment or retainer may be permanent or temporary, full-time or part-time. All Principal Investigators funded will be required to present their interim and final research results at the Maryland Stem Cell Symposium and in annual reports to the Commission.

About the Maryland St
'/>"/>

SOURCE Maryland Stem Cell Research Commission
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Maryland Approves Medicaid Reimbursement for ActiPatch(R)
2. Maryland Science Center Unveils Anatomical Exhibition, Body Worlds 2, on Saturday, February 2
3. University of Maryland, Baltimore BioPark Signs Gliknik Inc. as First Tenant in Its BioInnovation Center in Building Two
4. Maryland Stem Cell Commission Issues Nationwide Request for Applications for New Post-Doctoral Fellowship Grants
5. BioSpace Career Fair in Bethesda, Maryland Draws Hundreds of Industry Professionals
6. Hershey Center for Applied Research Supports Acceleration of Scientific Research and Development
7. Glowing zebrafish help researchers track role of sugars in the cell
8. eResearchTechnology Reports First Quarter 2008 Results
9. Roche Research Director Grace Ju Hailed as NJABR Outstanding Woman of Science
10. eResearchTechnology to Present at the Deutsche Bank 33rd Annual Healthcare Conference on May 7th 2008
11. EUSA Pharma Divests Monoclonal Antibody Research Business and Early-Stage Oncology Product
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... In recent years, growing suspicion about ... product development and promotion has led to unprecedented levels ... by concerns about the insidious impact of commercialization of ... fines to the world’s biggest pharmas for illegal marketing ...
(Date:1/14/2014)... Jan. 14, 2014   Kinaxis ®, provider of RapidResponse ... sales and operations planning ( S&OP ) service, is proud ... , which will be held at the Hilton San Diego ... Kinaxis customer Elisabeth Kaszas , Director of Supply Chain ...
(Date:1/14/2014)... During the 1600’s through the 1800’s doctors contributed unknowingly ... this time period, doctors did not know that they needed ... death of vulnerable patients. In the same way, medical interns ... unwittingly transmitting herpes viruses to their patients. The CBCD explains. ...
(Date:1/14/2014)... January 14, 2014 Holloway America today ... of material test reports (MTRs) for all pressure vessels ... test results is particularly important for equipment that must ... MTR Library features search functionality that allows authorized users ...
Breaking Biology Technology:The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 2The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 3Event Alert: Kinaxis Customer to Present at the Biomanufacturing Summit "Supply Chain: Improving Network Effectiveness" 2Study: Fatigued Medical Interns Infect Their Patients with Herpes Viruses; The CBCD Sees a Parallel with “The Doctor’s Plague” 2Study: Fatigued Medical Interns Infect Their Patients with Herpes Viruses; The CBCD Sees a Parallel with “The Doctor’s Plague” 3Pressure Vessel Design and Fabrication Company Builds Database for Material Test Reports 2Pressure Vessel Design and Fabrication Company Builds Database for Material Test Reports 3
... Data Reported by Roche at 69th Scientific Sessions , ... Inc. (Nasdaq: VIAP ), a biotechnology company ... of cardiovascular and metabolic disease, announced today that preclinical ... inhibitors will be presented in a poster presentation at ...
... , Thursday, June 11th, 10:00 a.m. EDT , , ... ) announced today that the Company President and Chief Executive Officer, ... on Thursday, June 11th, 2009 at 10:00 a.m. EDT, to report ... a quarterly update of the Company. , , This call ...
... initial steps towards producing Influenza A (H1N1) VLP vaccine for ... 4 Novavax, Inc. (Nasdaq: NVAX ) and ... National Institute of Allergy and Infectious Diseases (NIAID), National Institutes ... the evaluation of a virus-like particle (VLP) vaccine candidate against ...
Cached Biology Technology:VIA Pharmaceuticals' DGAT1 Inhibitors Featured in American Diabetes Association Poster Presentation 2VIA Pharmaceuticals' DGAT1 Inhibitors Featured in American Diabetes Association Poster Presentation 3VIA Pharmaceuticals' DGAT1 Inhibitors Featured in American Diabetes Association Poster Presentation 4Repligen Announces Conference Call of Fourth Quarter and Fiscal Year 2009 Results 2Repligen Announces Conference Call of Fourth Quarter and Fiscal Year 2009 Results 3Novavax and the NIH Agree to Evaluate a Virus-like Particle (VLP) Vaccine Candidate Against the Novel Influenza A (H1N1) Virus 2Novavax and the NIH Agree to Evaluate a Virus-like Particle (VLP) Vaccine Candidate Against the Novel Influenza A (H1N1) Virus 3Novavax and the NIH Agree to Evaluate a Virus-like Particle (VLP) Vaccine Candidate Against the Novel Influenza A (H1N1) Virus 4
(Date:4/23/2014)... Wash. -- Like a hungry diner ripping open a ... into electricity must tear open a hydrogen molecule. Now ... holding onto the two halves of its hydrogen feast. ... how to make the catalyst work better for alternative ... scientists have shown precisely where the hydrogen halves end ...
(Date:4/23/2014)... Putnam Valley, NY. (Apr. 23 2014) ... human neural stem cells (hNSCs) into the brains ... differentiation after 22 and 24 months found that ... months and did not cause tumors. , The ... of Cell Transplantation but is currently ...
(Date:4/23/2014)... evidence of an interaction between prenatal smoking and ... children, especially in girls. , "The interesting issue ... smoking will have behavioral problems. Some might, ... Professor at Sam Houston State University, College of ... "One possible explanation for this is that ...
Breaking Biology News(10 mins):Halving hydrogen 2Halving hydrogen 3Halving hydrogen 4Study finds long-term survival of human neural stem cells transplanted into primate brain 2Genetics risk, prenatal smoking may predict behavioral problems 2
... we are strong and healthy and then we weaken and die ... about. But, in nature, the phenomenon of ageing shows an unexpected ... The University of Southern Denmark. Not all species weaken ... get stronger and less likely to die with age, while others ...
... The addition of a monoclonal antibody called gemtuzumab combined ... the risk of relapse and increase rates of disease-free ... Post-treatment relapse rates are a major indicator of potential ... The study (abstract #355) evaluated a total of 1,022 ...
... EPA grant, NJIT established its Technical Assistance to Brownfield ... allow NJIT to continue to provide communities with scientific, ... Specifically, the grant allows the NJIT TAB team to ... Mid-Atlantic region. NJIT TAB is comprised of planners, environmental ...
Cached Biology News:Surprising diversity in aging revealed in nature 2Surprising diversity in aging revealed in nature 3Targeted treatment can significantly reduce relapse in children with AML leukemia 2EPA awards $1 million grant to NJIT's Brownfield program 2
RAT ANTI MOUSE F4/80 ANTIGEN:BIOTIN Immunogen: Thioglycollate stimulated peritoneal macrophages from C57/BL mice...
RABBIT ANTI PARATHION...
Recombinant Rhesus Monkey IFN-Alpha...
2,4-Dinitrophenyl hapten is conjugated to BSA (Bovine Serum Albumin) protein through lysine....
Biology Products: